-
[1]
Pinghu Zhang, Shuo Zhai, Jinhong Chang, Ju-Tao Guo, 2018: In Vitro Anti-hepatitis B Virus Activity of 2', 3'-Dideoxyguanosine, Virologica Sinica, 33, 538-544. doi: 10.1007/s12250-018-0065-7
-
[2]
Jun Wu, Ruth Bröring, Jörg F. Schlaak, 2008: The Role of the Innate Immune System of the Liver in the Control of HBV and HCV*, Virologica Sinica, 23, 116-123. doi: 10.1007/s12250-008-2942-y
-
[3]
赵文彬, 黄浦昌, 王行钵, 吴桃林, 周克捷, 张秀惠, 张元英, 林克泳, 1990: Efficacy of Treating Chronic Hepatitis B with HB Vaccine and Small Doses of Interferon and Thymosin, Virologica Sinica, 5, 379-.
-
[4]
黄华芳, 熊开钧, 王心禾, 曾令兰, 李嫒, 贺永文, 杨泽川, 凌美霞, 范家珍, 吴章琦, 1989: The Contrast Observation of Antiviral Effect of Interferon with Two Different Dosages in Chronic Hepatitis B, Virologica Sinica, 4, 383-.
-
[5]
Jie-Li Hu, Ai-Long Huang, 2024: Classifying hepatitis B therapies with insights from covalently closed circular DNA dynamics, Virologica Sinica, 39, 9-23. doi: 10.1016/j.virs.2023.12.005
-
[6]
田拥军, 覃莉, 张正茂, 李磊, 雷延昌, 喻植群, 赵西平, 杨东亮*, 2005: Study on a Transgenic Cell Line Stable Expression Gly145Arg Mutation HBsAg, Virologica Sinica, 20, 574-577.
-
[7]
Ju-sheng LIN, Lin-lin GAO, 2008: Advances in Research on Hepatitis B Virus DNA Integration, Virologica Sinica, 23, 93-99. doi: 10.1007/s12250-008-2939-6
-
[8]
Mengying Ji,, Kanghong Hu, 2017: Recent advances in the study of hepatitis B virus covalently closed circular DNA, Virologica Sinica, 32, 454-464. doi: 10.1007/s12250-017-4009-4
-
[9]
Jing Li, Yangyang Hu, Yifei Yuan, Yinan Zhao, Qiqi Han, Canyu Liu, Xue Hu, Yuan Zhou, Yun Wang, Yu Guo, Chunchen Wu, Xinwen Chen, Rongjuan Pei, 2021: Repurposing of Antazoline Hydrochloride as an Inhibitor of Hepatitis B Virus DNA Secretion, Virologica Sinica, 36, 501-509. doi: 10.1007/s12250-020-00306-2
-
[10]
邓卫文, 谢弘, 闻玉梅, 1997: The research of in vivo transfection of cloned duck hepatitis B virus DNA dimer, Virologica Sinica, 12, 66-.
-
[11]
谭维国, 李法卿, 吴玉强, 吴德福, 龚希平, 1994: Detection of HBsAgHBeAg and HBV DNA in Urinary cells of Patients with Hepatitis B an d HBsAg Carriers, Virologica Sinica, 9, 100-103.
-
[12]
吕冬梅, 陈尔佳, 谢天宏, 庄俊英, 刘勇, 李春宏, 孙茂盛, 戴长柏, 2001: DNA Immunization of Hepatitis E Virus(HEV), Virologica Sinica, 16, 131-134.
-
[13]
Yu Chen, Deyin Guo, 2016: Molecular mechanisms of coronavirus RNA capping and methylation, Virologica Sinica, 31, 3-11. doi: 10.1007/s12250-016-3726-4
-
[14]
Jianhao Cao, Shuhong Luo, Yuanyan Xiong, 2019: The Variability of Amino Acid Sequences in Hepatitis B Virus, Virologica Sinica, 34, 42-49. doi: 10.1007/s12250-018-0070-x
-
[15]
熊开钧, 黄华芳, 王心禾, 金慰鄂, 曾令兰, 杨泽川, 凌美霞, 张雪珍, 吴章琦, 1987: THE TREATMENT EFFECT OF HEPATITIS B WITH INTERFERON AND ACYCLOVIR, Virologica Sinica, 2, 17-.
-
[16]
熊开钧, 王心禾, 黄华芳, 姚梦林, 代家珠, 金慰鄂, 范红梅, 曾全兰, 张雪珍, 1987: THE OBSERVATION OF A TREATED RESULT WITH ACYCLOVIR IN HEPATITIS B VIRUS, Virologica Sinica, 2, 78-.
-
[17]
巫振欧, 管美英, 林胜清, 吴章琦, 1987: EFFICACY OF HUMAN LEUKOCYTESINTERFERON IN CHRONIC HEPATITIS B, Virologica Sinica, 2, 45-.
-
[18]
吴婷, 黄海, 1998: The Inhibitory Effects of Enduracidin on Hepatitis B Virus in vitro, Virologica Sinica, 13, 45-.
-
[19]
范涛, 傅希贤, 张国庆, 张乃临, 1994: The Inhibitory Effects of Quinolones on Hepatitis B Virus in Vitro, Virologica Sinica, 9, 113-118.
-
[20]
Yin-ping LU, Bao-ju WANG, Ji-hua DONG, Zhao LIU, Shi-he GUAN, Meng-ji LU, Dong-liang YANG, 2007: Construction and Characterization of a Hepatitis B Virus Replicon, Virologica Sinica, 22, 8-13.